Last reviewed · How we verify
NCT03671551: TODEVA
Study of Psychomotor Development and Attachment in Children Aged 6 to 30 Months With Oral Disorder
trial in Eating Disorders in Children in 1 participant. Terminated before completion.
20 November 2019
Quick facts
| Lead sponsor | Camille JUNG |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 1 |
| Start date | 19 November 2018 |
| Primary completion | 20 November 2019 |
| Estimated completion | 20 November 2019 |
| Sites | 2 locations across France |
Conditions studied
- Eating Disorders in Children — all drugs for Eating Disorders in Children →
- Psychomotor Development Impaired — all drugs for Psychomotor Development Impaired →
Sponsor
Camille JUNG
Who can join
Adults 6 Months to 30 Months, any sex, with Eating Disorders in Children or Psychomotor Development Impaired. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Dietary difficulties and eating disorders of the child are a common reason for consulting infants and young children. There is currently little data on the psychomotor development of these children and their association with parent-child attachment. The objective of this study is to evaluate, at the same time, the three physiological, psychomotor and attachment dimensions of children with eating disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03671551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03671551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Camille JUNG
- Last refreshed: 29 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03671551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing